{"id":405060,"date":"2020-12-23T08:03:22","date_gmt":"2020-12-23T13:03:22","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=405060"},"modified":"2020-12-23T08:03:22","modified_gmt":"2020-12-23T13:03:22","slug":"i-mab-announces-upcoming-participation-at-january-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-january-conferences\/","title":{"rendered":"I-Mab Announces Upcoming Participation at January Conferences"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">SHANGHAI<\/span> and <span class=\"xn-location\">GAITHERSBURG, Md.<\/span>, <span class=\"xn-chron\">Dec. 23, 2020<\/span> \/PRNewswire\/ &#8212; I-Mab (the &#8220;Company&#8221;) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences in January. Details of the conferences and management presentation are as follows:<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/821373\/I_MAB_Logo.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/821373\/I_MAB_Logo.jpg\" title=\"I-MAB Logo (PRNewsfoto\/I-Mab Biopharma)\" alt=\"I-MAB Logo (PRNewsfoto\/I-Mab Biopharma)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <b>H.C. Wainwright BioConnect 2021 Conference (Virtual)<br \/><\/b>Presentation: <span class=\"xn-chron\">Monday, January 11, 2021<\/span> at <span class=\"xn-chron\">6:00 a.m. EST<\/span><br \/>Presenters: Dr. <span class=\"xn-person\">Jingwu Zang<\/span>, Founder, Honorary Chairman and Director, Mr. Jielun Zhu, Director\u00a0and Chief Financial Officer, and Ms. <span class=\"xn-person\">Leah Liu<\/span>, Senior IR Director<\/p>\n<p>Webcast link: <a target=\"_blank\" href=\"https:\/\/journey.ct.events\/view\/55113ae1-5386-4315-9899-fa6c5550c2b9\" rel=\"nofollow noopener noreferrer\">https:\/\/journey.ct.events\/view\/55113ae1-5386-4315-9899-fa6c5550c2b9<\/a>. The webcast will also be available under &#8220;Event Calendar&#8221; on IMAB&#8217;s IR website at <a target=\"_blank\" href=\"http:\/\/ir.i-mabbiopharma.com\/\" rel=\"nofollow noopener noreferrer\">http:\/\/ir.i-mabbiopharma.com\/<\/a>.<\/p>\n<p>For more information, please contact your H.C. Wainwright representative. <\/p>\n<p>\n        <b>Citi Greater China Healthcare Corporate Day 2021 (Virtual)<br \/><\/b>Management participants: Dr. <span class=\"xn-person\">Jingwu Zang<\/span>, Founder, Honorary Chairman and Director, Dr. Joan Huaqiong Shen, Director and Chief Executive Officer, Mr. Jielun Zhu, Director\u00a0and\u00a0Chief Financial Officer, and Ms. <span class=\"xn-person\">Leah Liu<\/span>, Senior IR Director<\/p>\n<p>One-on-one and small group meetings: <span class=\"xn-chron\">January 14-15, 2021<\/span><\/p>\n<p>For more information, please contact your Citi representative. <\/p>\n<p>\n        <b>UBS Greater China Conference 2021 (Virtual)<br \/><\/b>Management participants: Dr. <span class=\"xn-person\">Jingwu Zang<\/span>, Founder, Honorary Chairman and Director, Dr. Joan Huaqiong Shen, Director and Chief Executive Officer, Mr. Jielun Zhu, Director and Chief Financial Officer, and Ms. <span class=\"xn-person\">Leah Liu<\/span>, Senior IR Director<\/p>\n<p>One-on-one and small group meetings: <span class=\"xn-chron\">January 18-22, 2021<\/span><\/p>\n<p>For more information, please contact your UBS representative. <\/p>\n<p>\n        <b>About I-Mab<\/b>\n      <\/p>\n<p>I-Mab (Nasdaq: IMAB) is a dynamic, global biotech company exclusively focused on discovery, development and soon commercialization of novel or highly differentiated biologics in the therapeutic areas of immuno-oncology and autoimmune diseases. The Company&#8217;s mission is to bring transformational medicines to patients around the world through innovation. I-Mab&#8217;s innovative pipeline of more than 10 clinical and pre-clinical stage drug candidates is driven by the Company&#8217;s Fast-to-PoC (Proof-of-Concept) and Fast-to-Market development strategies through internal R&amp;D and global partnerships. The Company is on track to transitioning from a clinical stage biotech company toward a fully integrated global biopharmaceutical company with cutting-edge R&amp;D capabilities, world-class GMP manufacturing facility and commercial capability. I-Mab has offices in <span class=\"xn-location\">Beijing<\/span>, <span class=\"xn-location\">Shanghai<\/span>, <span class=\"xn-location\">Hangzhou<\/span>, <span class=\"xn-location\">Hong Kong<\/span> and <span class=\"xn-location\">Maryland<\/span>, <span class=\"xn-location\">United States<\/span>. For more information, please visit <a target=\"_blank\" href=\"http:\/\/ir.i-mabbiopharma.com\/\" rel=\"nofollow noopener noreferrer\">http:\/\/ir.i-mabbiopharma.com<\/a>\u00a0and follow I-Mab on <a target=\"_blank\" href=\"https:\/\/www.linkedin.com\/company\/i-mab\/\" rel=\"nofollow noopener noreferrer\">LinkedIn<\/a>, <a target=\"_blank\" href=\"https:\/\/twitter.com\/IMabBiopharma\" rel=\"nofollow noopener noreferrer\"><span id=\"spanHghlta73f\">Twitter<\/span><\/a><span id=\"spanHghlta7f4\">\u00a0and <\/span><a target=\"_blank\" href=\"https:\/\/mp.weixin.qq.com\/s\/_s634aizyQPuq1Vgf-hLGA\" rel=\"nofollow noopener noreferrer\"><span id=\"spanHghlt956e\">WeChat<\/span><\/a><span id=\"spanHghltb47c\">.<\/span><\/p>\n<p>\n        <b>For more information, please contact:<\/b>\n      <\/p>\n<p>\n        <b>I-Mab<\/b>\n      <\/p>\n<p>Jielun Zhu, Chief Financial Officer<br \/>E-mail: <a target=\"_blank\" href=\"mailto:jielun.zhu@i-mabbiopharma.com\" rel=\"nofollow noopener noreferrer\">jielun.zhu@i-mabbiopharma.com<\/a><br \/>Office line: +86 21 6057 8000<\/p>\n<p>\n        <span class=\"xn-person\">Gigi Feng<\/span>, Chief Communications Officer<br \/>E-mail: <a target=\"_blank\" href=\"mailto:gigi.feng@i-mabbiopharma.com\" rel=\"nofollow noopener noreferrer\">gigi.feng@i-mabbiopharma.com<\/a><br \/>Office line: +86 21 6057 5785<\/p>\n<p>\n        <b>Investor Inquiries:<\/b>\n      <\/p>\n<p>\n        <i>The Piacente Group, Inc.<br \/><\/i><br \/>\n        <span class=\"xn-person\">Emilie Wu<\/span><br \/>\n        <br \/>E-mail: <a target=\"_blank\" href=\"mailto:emilie@thepiacentegroup.com\" rel=\"nofollow noopener noreferrer\">emilie@thepiacentegroup.com<\/a><br \/>Office line: + 86 21 6039 8363<\/p>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN32656&amp;sd=2020-12-23\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/i-mab-announces-upcoming-participation-at-january-conferences-301198031.html\">http:\/\/www.prnewswire.com\/news-releases\/i-mab-announces-upcoming-participation-at-january-conferences-301198031.html<\/a><\/p>\n<p>SOURCE  I-Mab<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=CN32656&amp;Transmission_Id=202012230800PR_NEWS_USPR_____CN32656&amp;DateId=20201223\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire SHANGHAI and GAITHERSBURG, Md., Dec. 23, 2020 \/PRNewswire\/ &#8212; I-Mab (the &#8220;Company&#8221;) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences in January. Details of the conferences and management presentation are as follows: H.C. Wainwright BioConnect 2021 Conference (Virtual)Presentation: Monday, January 11, 2021 at 6:00 a.m. ESTPresenters: Dr. Jingwu Zang, Founder, Honorary Chairman and Director, Mr. Jielun Zhu, Director\u00a0and Chief Financial Officer, and Ms. Leah Liu, Senior IR Director Webcast link: https:\/\/journey.ct.events\/view\/55113ae1-5386-4315-9899-fa6c5550c2b9. The webcast will also be available under &#8220;Event Calendar&#8221; on IMAB&#8217;s IR website at http:\/\/ir.i-mabbiopharma.com\/. For more information, please contact your H.C. Wainwright representative. Citi Greater China Healthcare Corporate Day &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-january-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;I-Mab Announces Upcoming Participation at January Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-405060","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>I-Mab Announces Upcoming Participation at January Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-january-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"I-Mab Announces Upcoming Participation at January Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SHANGHAI and GAITHERSBURG, Md., Dec. 23, 2020 \/PRNewswire\/ &#8212; I-Mab (the &#8220;Company&#8221;) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences in January. Details of the conferences and management presentation are as follows: H.C. Wainwright BioConnect 2021 Conference (Virtual)Presentation: Monday, January 11, 2021 at 6:00 a.m. ESTPresenters: Dr. Jingwu Zang, Founder, Honorary Chairman and Director, Mr. Jielun Zhu, Director\u00a0and Chief Financial Officer, and Ms. Leah Liu, Senior IR Director Webcast link: https:\/\/journey.ct.events\/view\/55113ae1-5386-4315-9899-fa6c5550c2b9. The webcast will also be available under &#8220;Event Calendar&#8221; on IMAB&#8217;s IR website at http:\/\/ir.i-mabbiopharma.com\/. For more information, please contact your H.C. Wainwright representative. Citi Greater China Healthcare Corporate Day &hellip; Continue reading &quot;I-Mab Announces Upcoming Participation at January Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-january-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-23T13:03:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/821373\/I_MAB_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-announces-upcoming-participation-at-january-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-announces-upcoming-participation-at-january-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"I-Mab Announces Upcoming Participation at January Conferences\",\"datePublished\":\"2020-12-23T13:03:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-announces-upcoming-participation-at-january-conferences\\\/\"},\"wordCount\":446,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-announces-upcoming-participation-at-january-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/821373\\\/I_MAB_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-announces-upcoming-participation-at-january-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-announces-upcoming-participation-at-january-conferences\\\/\",\"name\":\"I-Mab Announces Upcoming Participation at January Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-announces-upcoming-participation-at-january-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-announces-upcoming-participation-at-january-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/821373\\\/I_MAB_Logo.jpg\",\"datePublished\":\"2020-12-23T13:03:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-announces-upcoming-participation-at-january-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-announces-upcoming-participation-at-january-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-announces-upcoming-participation-at-january-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/821373\\\/I_MAB_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/821373\\\/I_MAB_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-announces-upcoming-participation-at-january-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"I-Mab Announces Upcoming Participation at January Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"I-Mab Announces Upcoming Participation at January Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-january-conferences\/","og_locale":"en_US","og_type":"article","og_title":"I-Mab Announces Upcoming Participation at January Conferences - Market Newsdesk","og_description":"PR Newswire SHANGHAI and GAITHERSBURG, Md., Dec. 23, 2020 \/PRNewswire\/ &#8212; I-Mab (the &#8220;Company&#8221;) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences in January. Details of the conferences and management presentation are as follows: H.C. Wainwright BioConnect 2021 Conference (Virtual)Presentation: Monday, January 11, 2021 at 6:00 a.m. ESTPresenters: Dr. Jingwu Zang, Founder, Honorary Chairman and Director, Mr. Jielun Zhu, Director\u00a0and Chief Financial Officer, and Ms. Leah Liu, Senior IR Director Webcast link: https:\/\/journey.ct.events\/view\/55113ae1-5386-4315-9899-fa6c5550c2b9. The webcast will also be available under &#8220;Event Calendar&#8221; on IMAB&#8217;s IR website at http:\/\/ir.i-mabbiopharma.com\/. For more information, please contact your H.C. Wainwright representative. Citi Greater China Healthcare Corporate Day &hellip; Continue reading \"I-Mab Announces Upcoming Participation at January Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-january-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-23T13:03:22+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/821373\/I_MAB_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-january-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-january-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"I-Mab Announces Upcoming Participation at January Conferences","datePublished":"2020-12-23T13:03:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-january-conferences\/"},"wordCount":446,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-january-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/821373\/I_MAB_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-january-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-january-conferences\/","name":"I-Mab Announces Upcoming Participation at January Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-january-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-january-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/821373\/I_MAB_Logo.jpg","datePublished":"2020-12-23T13:03:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-january-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-january-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-january-conferences\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/821373\/I_MAB_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/821373\/I_MAB_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-january-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"I-Mab Announces Upcoming Participation at January Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/405060","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=405060"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/405060\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=405060"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=405060"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=405060"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}